ATE275191T1 - Methoden für die immunoempfängnisverhütung - Google Patents

Methoden für die immunoempfängnisverhütung

Info

Publication number
ATE275191T1
ATE275191T1 AT94902225T AT94902225T ATE275191T1 AT E275191 T1 ATE275191 T1 AT E275191T1 AT 94902225 T AT94902225 T AT 94902225T AT 94902225 T AT94902225 T AT 94902225T AT E275191 T1 ATE275191 T1 AT E275191T1
Authority
AT
Austria
Prior art keywords
zona pellucida
immunocontraception
methods
proteins
specific
Prior art date
Application number
AT94902225T
Other languages
English (en)
Inventor
Jeffrey D Harris
Kuang T Hsu
Joseph S Podolski
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Application granted granted Critical
Publication of ATE275191T1 publication Critical patent/ATE275191T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT94902225T 1992-11-09 1993-11-06 Methoden für die immunoempfängnisverhütung ATE275191T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97334192A 1992-11-09 1992-11-09
US1299093A 1993-01-29 1993-01-29
PCT/US1993/010851 WO1994011019A1 (en) 1992-11-09 1993-11-06 Materials and methods for immunocontraception

Publications (1)

Publication Number Publication Date
ATE275191T1 true ATE275191T1 (de) 2004-09-15

Family

ID=32965094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902225T ATE275191T1 (de) 1992-11-09 1993-11-06 Methoden für die immunoempfängnisverhütung

Country Status (9)

Country Link
US (5) US6027727A (de)
EP (1) EP0634936B1 (de)
JP (1) JPH07503142A (de)
CN (1) CN1110177A (de)
AT (1) ATE275191T1 (de)
AU (1) AU675269B2 (de)
CA (1) CA2127531A1 (de)
DE (1) DE69333610D1 (de)
WO (1) WO1994011019A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE37224E1 (en) * 1992-06-05 2001-06-12 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
AU2096199A (en) * 1998-01-02 1999-07-26 University Of Georgia Research Foundation, Inc., The Fertility impairing vaccine and method of use
US7019114B2 (en) * 1998-02-19 2006-03-28 Eastern Virginia Medical School Recombinant, biologically active human zona pellucida protein 3 (HZP3) to test male fertility
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
US6455041B1 (en) * 1998-11-17 2002-09-24 Bonita S. Dunbar Immunogenic epitopes of the human zona pellucida protein (ZP1)
PT1218405E (pt) 1999-03-17 2015-11-23 Biosyn Arzneimittel Gmbh Hemocianina e sequência de ácidos nucleicos codificante para hemocianina
DE19939578A1 (de) * 1999-08-20 2001-02-22 Biosyn Arzneimittel Gmbh Nukleinsäuremolekül, umfassend eine für ein Hämocyanin kodierende Nukleinsäuresequenz
AU2001261968A1 (en) * 2000-05-25 2001-12-03 Oregon Health Sciences University Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
ATE513851T1 (de) * 2000-10-18 2011-07-15 Us Gov Health & Human Serv Menschliches gen zur fruchtbarkeit entscheidend
EP1421104A4 (de) * 2001-08-02 2005-08-24 Trinity Biomedical Technology Humane zona-pellucida-proteine und verfahren zu deren verwendung bei der diagnose männlicher unfruchtbarkeit
US20030181409A1 (en) * 2001-12-14 2003-09-25 The Regents Of The University Of California Methods of inhibiting fertility
EP1474447A2 (de) * 2002-02-08 2004-11-10 Immunovaccine Technologies Inc. Antigene zur immuno-schwangerschaftsverhütung
US7056515B2 (en) 2002-02-08 2006-06-06 Immunovaccine Technologies Inc. Antigens for immunocontraception
US7309495B2 (en) * 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
EP1606391B1 (de) * 2003-03-14 2011-01-19 Regents of the University of California Virulentes systemisches felines calicivirus
US7639629B2 (en) * 2006-07-28 2009-12-29 Microsoft Corporation Security model for application and trading partner integration
US20080187549A1 (en) * 2007-02-07 2008-08-07 Morey William A Polyantigenic-based (multiple antigens) modi or set of methods for developing infertility vaccines
US20090090367A1 (en) * 2007-10-03 2009-04-09 Hurley Scott B Method of contraception
EP2344193B1 (de) * 2008-09-17 2013-10-02 The Government Of The United States Of America As Reresented By The Secretary Of The Department Of Health & Human Services Rekombinante immunkontrazeptive zusammensetzungen auf basis des tollwut-virus und anwendungsverfahren
CN107158373B (zh) * 2017-05-25 2021-06-11 新疆大学 阿魏菇多糖在制备犬透明带3dna疫苗佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
AU636895B2 (en) * 1989-06-12 1993-05-13 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Contraceptive vaccine based on cloned zona pellucida gene
IE912872A1 (en) * 1990-08-27 1992-03-11 Akzo Nv Human zona pellucida protein zp3
JPH05317050A (ja) * 1992-01-10 1993-12-03 Shinzou Isojima Ｐｚｐ−４遺伝子及び避妊ワクチン
WO1993014786A1 (en) * 1992-02-04 1993-08-05 Colorado State University Research Foundation Composition and method to prevent conception or to cause sterility in animals

Also Published As

Publication number Publication date
EP0634936A4 (de) 1998-07-15
US5976545A (en) 1999-11-02
DE69333610D1 (de) 2004-10-07
CA2127531A1 (en) 1994-05-26
US5981228A (en) 1999-11-09
WO1994011019A1 (en) 1994-05-26
EP0634936A1 (de) 1995-01-25
EP0634936B1 (de) 2004-09-01
JPH07503142A (ja) 1995-04-06
CN1110177A (zh) 1995-10-18
US5837497A (en) 1998-11-17
AU5680094A (en) 1994-06-08
US5989550A (en) 1999-11-23
AU675269B2 (en) 1997-01-30
US6027727A (en) 2000-02-22

Similar Documents

Publication Publication Date Title
ATE275191T1 (de) Methoden für die immunoempfängnisverhütung
CO4700344A1 (es) Vacuna polinucleotidica para bovinos por via intradermica
FI932678A0 (fi) Pao alfavirus baserande DNA expressionssystem
JPS56154999A (en) Synthesis of selective aged protein or polypeptide in bacteria matrix
PT87394A (pt) Process for plant tissue transformation
DK0663010T3 (da) Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner
ATE258189T1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
DE69734936D1 (de) Wirtszellen und methoden für die produktion von proteinen
ES2091768T3 (es) Factor neurotrofico ciliar purificado.
DE69637807D1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
DE3650135D1 (de) Proteingewinnung.
ES2151506T3 (es) Moleculas de adn recombinante que codifican enzimas aminopeptidasa y su uso en la preparacion de vacunas contra infecciones por helmintos.
GB2316411A (en) Nucleic Acid Sequencing Gels
DE69535696D1 (de) Tripeptidyl-aminopeptidase
KR960010863A (ko) 재조합 머사시딘 및 이의 제조방법
DE3683447D1 (de) Verfahren zur herstellung von humanlysozym.
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
DE69010096D1 (de) Expression und Sekretion von reifem menschlichem beta-Interleukin-1 in Bacillus subtilis und Mittel und Verfahren zu deren Ausführung.
DE69734586D1 (de) Retinoid-metabolisierendes protein
DE59510829D1 (de) Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen
ATE132905T1 (de) Methode der reinigung von proteinen
ES2112289T3 (es) Procedimiento de biosintesis para la preparacion de proteinas.
DE69739880D1 (de) NUKLEINSÄURELIGANDEN MIT HOHER AFFINITÄT FÜR DAS C1q PROTEIN DES KOMPLEMENTSYSTEMS
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
ATE201448T1 (de) Impfstoffe auf der basis von streptokinase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties